Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • Latest news
  • Worldwide impact of NIBSC
  • Mission and values
  • Careers
  • Quality and governance
  • Staff profiles
  • Contact us
  • Collaborations
  • Suppliers
  • Scientific Advisory Committee
  • Minutes of the Animal Welfare and Ethical Review Body
  • Our use of animals
  • Privacy notice
  • Home  /  
  • About us  /  
  • Latest news  /  
  • CE-marked Clinical Virology Multiplex I

CE-marked Clinical Virology Multiplex I: Immunodeficiency Panel for NAT

hand with vial

NIBSC are pleased to announce a further expansion to our range of CE-marked Clinical Virology working reagents for Nucleic Acid Amplification Tests (NAT); the Clinical Virology Multiplex I: Immunodeficiency Panel.

The new multiplex Immunodeficiency Panel has been developed in collaboration with Clinical Diagnostic Virology laboratories across the UK in accordance with ISO 13485.  The freeze-dried preparation combines 11 analytes, AdV-2, BKV, HCMV, EBV, HHV-6A, HHV-6B, HSV-1, HSV-2, JCV, B19 and VZV, five of which have been assigned an International Unit.

The whole virus preparation can be extracted and amplified alongside unknown samples to monitor assay performance, enabling inter - and intra - laboratory comparisons, that form part of a continuing quality control programme and is an essential requirement of ISO 15189. The reconstituted material can be stored at or below 2-8°C for up to seven days.

 
 
 
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap